4-47031697-C-G
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_000812.4(GABRB1):c.46C>G(p.Pro16Ala) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P16H) has been classified as Uncertain significance.
Frequency
Consequence
NM_000812.4 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 45Inheritance: AD Classification: STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000812.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| GABRB1 | TSL:1 MANE Select | c.46C>G | p.Pro16Ala | missense | Exon 1 of 9 | ENSP00000295454.3 | P18505-1 | ||
| GABRB1 | TSL:1 | n.147C>G | non_coding_transcript_exon | Exon 1 of 4 | |||||
| GABRB1 | TSL:4 | c.-19-217C>G | intron | N/A | ENSP00000426753.1 | D6REM0 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 32
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at